VENUS REMEDIES
Back to Cashflow Statement
|
VENUS REMEDIES Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-3.12 Cr | ₹-1.02 Cr | ₹-1.08 Cr | ₹-0.57 Cr | ₹-9.48 Cr |
What is the latest Cash Flow from Financing Activities ratio of VENUS REMEDIES ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2026 | ₹-3.12 Cr |
| Mar2025 | ₹-1.02 Cr |
| Mar2024 | ₹-1.08 Cr |
| Mar2023 | ₹-0.57 Cr |
| Mar2022 | ₹-9.48 Cr |
How is Cash Flow from Financing Activities of VENUS REMEDIES Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-3.12 Cr | Negative | |
| Mar2025 | ₹-1.02 Cr | Negative | |
| Mar2024 | ₹-1.08 Cr | Negative | |
| Mar2023 | ₹-0.57 Cr | Negative | |
| Mar2022 | ₹-9.48 Cr | - | |
Compare Cash Flow from Financing Activities of peers of VENUS REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VENUS REMEDIES | ₹2,185.2 Cr | -6.9% | 0.4% | 262.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹421,539.0 Cr | -1.4% | -6.6% | 7.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹247,576.0 Cr | 1.2% | -2.6% | 60% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹177,251.0 Cr | -2% | -6.1% | 33% | Stock Analytics | |
| CIPLA | ₹105,290.0 Cr | -2.3% | -5.8% | -13.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,752.6 Cr | -1.1% | 3.8% | -5.5% | Stock Analytics | |
VENUS REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VENUS REMEDIES | -6.9% |
0.4% |
262.4% |
| SENSEX | 0.8% |
-4.8% |
-10.5% |
You may also like the below Video Courses